• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Comput Sci . Harnessing low dimensionality to visualize the antibody-virus landscape for influenza

tetano

Editor, Senior Moderator
Nat Comput Sci


. 2023 Feb;3(2):164-173.
doi: 10.1038/s43588-022-00375-1. Epub 2022 Dec 30. Harnessing low dimensionality to visualize the antibody-virus landscape for influenza

Tal Einav[SUP] #[/SUP][SUP] 1 [/SUP], Adrian Creanga[SUP] #[/SUP][SUP] 2 [/SUP], Sarah F Andrews[SUP] 2 [/SUP], Adrian B McDermott[SUP] 2 [/SUP], Masaru Kanekiyo[SUP] 2 [/SUP]



Affiliations
Abstract

Antibodies constitute a key line of defense against the diverse pathogens we encounter in our lives. Although the interactions between a single antibody and a single virus are routinely characterized in exquisite detail, the inherent tradeoffs between attributes such as potency and breadth remain unclear. Moreover, there is a wide gap between the discrete interactions of single antibodies and the collective behavior of antibody mixtures. Here we develop a form of antigenic cartography called a 'neutralization landscape' that visualizes and quantifies antibody-virus interactions for antibodies targeting the influenza hemagglutinin stem. This landscape transforms the potency-breadth tradeoff into a readily solvable geometry problem. With it, we decompose the collective neutralization from multiple antibodies to characterize the composition and functional properties of the stem antibodies within. Looking forward, this framework can leverage the serological assays routinely performed for influenza surveillance to analyze how an individual's antibody repertoire evolves after vaccination or infection.


 
Back
Top Bottom